Harte Hanks (HHS) Return on Equity (2011 - 2026)

Harte Hanks (HHS) has 16 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Equity rose 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Equity eased to 0.0% in Q1 2026 per HHS's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.12% in Q4 2022 and bottomed at 0.01% in Q2 2024.
• The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.0%.
• The widest annual swing landed in 2022, when Return on Equity advanced 13 bps; it then fell 12 bps in 2023.
• Tracing HHS's Return on Equity over 5 years: stood at 0.12% in 2022, then sank by 101 bps to 0.0% in 2023, then slumped by 1686 bps to 0.01% in 2024, then surged by 97 bps to 0.0% in 2025, then retreated by 29 bps to 0.0% in 2026.
• Per Business Quant, the three latest HHS Return on Equity figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison